Psychedelics Saves Lives: The Future of Psychopharmacology

Psychedelics Saves Lives: The Future of Psychopharmacology

“There are two great beings who invented psychedelics: God and Sasha Shulgin.”—James Fadimen

Would you take a pill that worked 80% or 20% of the time? Medicine was once viewed as what you were eating. People treated everything they put in their body as medicine.  All of your drugs in your medicine cabinet could potentially kill you, if you take enough, hell, water could kill you if you drank too much of it. Psychedelics have no LD 50 rate, meaning lethal dose for 50% of the human population, entheogens can’t and will never kill you, unless you jump out a 10-story window high on LSD.  A mouse tries cocaine in a water bottle and every time they will do over and over again until it overdoses and dies. A mouse tries LSD in a water bottle once, and never does it again. It (psychedelics) has, and has the potential to cure: addiction, depression, anxiety, autism, PTSD, OCD, schizophrenia, bi-polar disorder, etc.

I was nearing the end of the year in 2016, in my intro psychology class, it was one of my last classes. That class we were talking about my favorite topic: drugs. At the end of the class, my teacher warned people not to do psilocybin mushrooms because she claimed it would make our brains bleed. Which couldn’t be further away from the truth, in fact, magic mushrooms have shown to literally expand the mind by growing, and re-growing braincells. I stayed a half hour after class referencing the many studies that have shown that psychedelics have been curing depression, anxiety, many types of addictions, and other mental health issues. Just like the most effective therapies, people under the influence of psychedelics were put into a FMRI machine to scan their brains. It showed that both their conscious and unconscious mind were blended together, lighting up all parts of the brain. It was like the awaken and the REM sleep brain were working together. Just like Eye Movement Desterilization and Reprocessing (EMDR), Emotional Freedom Technique (EFT), Craniosacral Therapy (CST), Trauma-Sensitive Yoga (TSY), or people under hypnosis, they mesh your conscious and unconscious awareness together to help get over whatever it is you are dealing with, and or what don’t know what is bothering them, as it has been stuck in your unconscious mind. Those are just some of the over 100 therapies psychotherapist’s offer nowadays. Psychedelics brings it out of you instantaneously, especially those who are being guided through their session. That is why when people are having a bad trip, they fail to recognize that your unconscious mind is trying to tell you something, and the more you ignore it, the worse the trip gets—some feel like there are about to die. Needless to say, that professor the next class retracted her statement, and now teaches her class the healing power of these beautiful substances.

The co-founder of Alcoholics Anonymous (AA): Bill Wilson, which is the non-profit support group for alcoholics, and other substance abusers. AA itself helped cure Bill’s alcoholism in 1939. But, he still had debilitating depression, which almost drove him to suicide until the early 1950’s. He one-night set-up by his father and the late great Aldous Huxley, at the Veterans Administration hospital in Los Angeles, cured his depression through LSD assisted psychotherapy (back then it was totally legal). Under the supervision of Dr. Sidney Cohen with Gerald Heard, a trusted spiritual mentor, as his guide, Bill had his first experience with LSD August 29, 1956. After that time Bill made it his goal to make LSD the 13th and final step of the AA 12-step program. He was quickly thrown out of AA, the fucking non-profit he started! He recognized back then that AA ignores the trauma side of things which causes the addiction in the 1st place. LSD assisted therapy cures and helps one deal with the trauma associated with their addiction.

MDMA right now is getting fast tract through the FDA to make it legal for therapy. Thanks to one of my personal heroes: Alexander Shulgin in the late 1970’s re-synthesized MDMA and said to many psychotherapists throughout the states, that maybe you guys should look into this drug used with a guided psychotherapy session. Shulgin tried a new drug every week for over 50 years up until his death at 88-years-old. He banked enough psychedelic drugs that he could easily replace all pharmaceutical drugs we use today, and they would be way better for us, with a hell of a lot less side effects.

LSD was one of the first drugs ever properly studied in the early 1950’s. They quickly discovered serotonin as LSD mimics serotonin, because of this discovery we wouldn’t have the psyche meds we have today, or at least we wouldn’t have had them as fast as we did. In the late 1960’s James Fadimen a psychologist took 48 people who were either scientists, architects, doctors of all sorts, that were working on something within their filed that hadn’t been yet figured out with a patent, product, math or science problem, and or a publication. Some people had been working on their complications for over 20 years. After one LSD therapy session: 44 of the 48 people figured out their problems.

Never do psychedelic drugs unless under the supervision of a doctor/guide. You need a babysitter.

Suggested dosages:

Heroic dose: Ethnobotanist Terrance Mckenna coined the term “heroic does,” which is often equated to 5 or more grams of mushrooms or more than 400 mcg of LSD. This dose is not recommended.

400 mcg is where you have transcendental or mystical experience. At this dose or higher, it is critical to have qualified supervision in a form of a guide.

200 mcg can be used for psychotherapy, self-exploration, deep inner work, and healing.

100 mcg is useful for creative problems solving with non-personal matters. A number of Nobel Prize laureates in chemistry, biology, and elsewhere attribute breakthroughs to LSD

If you have a predisposition to schizophrenia or bi-polar probably too fucked up on a results basis they don’t even have to try it because they seem like they’re on psychedelics as it is way too much as it is, probably should not par take in the experience, as that is there life. We one day may find a cure for it though through psychedelics. Until that time, those who suffer those heavy of a mental illness or someone in their immediate family has it, you should hold off for now.

The many studies now involving people who are addicted to the cancer killing cigarettes and have them each a dose of mushrooms with a guided therapy session. After a year on average: 67% of the participants abstained from smoking. Now comparing that to people who tried Chantix, which is the most helpful drug besides now psychedelics, only helped as much as 20% of people quit smoking and Nicorette gum, or the nicotine patch, helped significantly less people.

Ram Dass, formely known as: Richard Alpert, who quit being a professor along with Timothy Leary (remember from 1967 “Turn on, tune in, drop out?”) gave his Guru 600 micrograms Masha Riri who never had taken a psychedelic prior, asked for the biggest dose Ram Dass would give him, and Masha Riri began to go crazy, yelling and making all sorts of weird jesters, as Ram Dass started freaking out thinking oh my God! What have I done to my Guru! Then Riri started laughing, as it was all a big joke and it literally didn’t affect him whatsoever. People can achieve the exact same altered states of consciousness through meditation/yoga/float tanks/etc. For me, it took about five years of a solid a meditation/yoga almost everyday practice, as well as utilizing float tanks, and Ibogaine helped speed up the ever so slow but well worth it practice. Suicide, depression, anxiety, is growing exponentially. We haven’t had much going on with pharmaceuticals since the early 90’s to help treat these mental illnesses. So even the FDA is getting desperate to help treat the millions of people suffering around the world.

In the Pineal gland in mice they found it produced DMT. When dreaming the brain makes DMT in humans, DMT is also produced throughout the body and throughout nature. There are some cultures now and many, many before us don’t use psychedelics recreationally. They use it once a year and if people use it outside of that they are punished.

 

Here our some of the many studies on going on to observe how effective psychedelics can positively be:

 

https://aaagnostica.org/2015/05/10/bill-wilsons-experience-with-lsd/

Alexander ‘Sasha’ Shulgin

 

Studies:

John Hopkins: Hallucinogenic drug found in ‘magic mushrooms’ eases depression, anxiety in people with life-threatening cancer.

In a small double-blind study, Johns Hopkins researchers report that a substantial majority of people suffering cancer-related anxiety or depression found considerable relief for up to six months from a single large dose of psilocybin—the active compound in hallucinogenic “magic mushrooms.”

https://hub.jhu.edu/2016/12/01/hallucinogen-treats-cancer-depression-anxiety/

 

John Hopkins: Study explores the enduring positive, negative consequences of ingesting ‘magic mushrooms’

In a survey of almost 2,000 people who said they had a past negative experience when taking “magic mushrooms” containing the hallucinogen psilocybin, more than 10 percent said they believed their worst “bad trip” had put themselves or others in harm’s way, according to researchers at Johns Hopkins.

A substantial majority of survey respondents called their most distressing episode one of the top 10 biggest challenges of their lives, though most also reported the experience to be “meaningful” or “worthwhile,” with half of these positive responses claiming it as one of the most valuable experiences in their life.

https://hub.jhu.edu/2017/01/04/bad-trips-mushrooms/

 

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

After a hiatus of some 40 years, clinical research has resumed on the use of classic hallucinogens to treat addiction. Following completion of a small open-label feasibility study, we are currently conducting a double-blind placebo-controlled clinical trial of psilocybin-assisted treatment of alcohol use disorder. Although treatment effects cannot be analyzed until the study is complete, descriptive case studies provide a useful window into the therapeutic process of psychedelic-assisted treatment of addiction. Here we describe treatment trajectories of three participants in the ongoing trial to illustrate the range of experiences and persisting effects of psilocybin treatment. Although it is difficult to generalize from a few cases, several qualitative conclusions can be drawn from the data presented here. Although participants often find it difficult to describe much of their psilocybin experience, pivotal moments tend to be individualized, extremely vivid, and memorable. Often, the qualitative content extends beyond the clinical problem that is being addressed. The participants discussed in this paper experienced acute and lasting alterations in their perceptions of self, in the quality of their baseline consciousness, and in their relationship with alcohol and drinking. In these cases, experiences of catharsis, forgiveness, self-compassion, and love were at least as salient as classic mystical content. Finally, feelings of increased “spaciousness” or mindfulness, and increased control over choices and behavior were reported following the drug administration sessions. Ultimately, psilocybin-assisted treatment appears to elicit experiences that are extremely variable, yet seem to meet the particular needs of the individual.

 

https://www.frontiersin.org/articles/10.3389/fphar.2018.00100/full

 

Long-term follow-up of psilocybin-facilitated smoking cessation.

 

All 15 participants completed a 12-month follow-up, and 12 (80%) returned for a long-term (≥16 months) follow-up, with a mean interval of 30 months (range = 16-57 months) between target-quit date (i.e., first psilocybin session) and long-term follow-up. At 12-month follow-up, 10 participants (67%) were confirmed as smoking abstinent. At long-term follow-up, nine participants (60%) were confirmed as smoking abstinent. At 12-month follow-up 13 participants (86.7%) rated their psilocybin experiences among the five most personally meaningful and spiritually significant experiences of their lives.

CONCLUSION:

These results suggest that in the context of a structured treatment program, psilocybin holds considerable promise in promoting long-term smoking abstinence. The present study adds to recent and historical evidence suggesting high success rates when using classic psychedelics in the treatment of addiction. Further research investigating psilocybin-facilitated treatment of substance use disorders is warranted.

https://www.ncbi.nlm.nih.gov/pubmed/27441452

 

Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence.

https://www.ncbi.nlm.nih.gov/pubmed?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17523581&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

 

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.

https://www.ncbi.nlm.nih.gov/pubmed/17196053?dopt=AbstractPlus

 

Report on psychoactive drug use among adolescents using ayahuasca within a religious context.

https://www.ncbi.nlm.nih.gov/pubmed/16149326?dopt=AbstractPlus

 

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.

https://www.ncbi.nlm.nih.gov/pubmed/12495789?dopt=Abstract

 

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *